Review



nrf2  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    MedChemExpress nrf2
    Nrf2, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 270 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-p10530/Nrf2/pm33626394-33-7-17
    Average 97 stars, based on 270 article reviews
    nrf2 - by Bioz Stars, 2026-10
    97/100 stars

    Images

    Related Articles

    other:

    Article Title: RBM15 impairs Hepatic Mitochondria and β-Oxidation through m 6 A-dependent degradation of MCM3 mRNA.
    Article Snippet: Primary mouse hepatocytes were isolated from male C57BL/6J mice (8-week-old) were purchased from (Vitalriver) via collagenase perfusion and cultured in low‐glucose DMEM (Gibco, MD, USA, 11885084) containing 10% FBS (Gibco) at 37°C with 5% CO2.

    Incubation:

    Article Title: Liraglutide combined with dapagliflozin treatment improves myocardial disease and endothelial dysfunction in T2DM mice
    Article Snippet: Protein samples were denatured and then separated by SDS‐PAGE on 12% polyacrylamide gels, followed by transfer onto nitrocellulose membranes (66,485, Pall). .. Membranes were blocked with 5% (w/v) non‐fat milk (A600669‐0250, Sangon Biotech) in TBST for 1.5 h at room temperature and then incubated overnight at 4°C with the following primary antibodies at specified dilutions: TNF‐α (1:1,000, 17590‐1‐AP, Proteintech), IL‐1β (1:1,000, AF5103, Affinity), IL‐6 (1:500, GB11117, Servicebio), Bax (1:8,000, 50599‐2‐Ig, Proteintech), BCl‐2 (1:1,000, AF6139, Affinity), cleaved caspase‐3 (1:1,000, AF7022, Affinity), 3‐NT (1:1,000, HY‐ P81216 , MCE), NRF2 (1:1,000, BF8017, Affinity), HO‐1 (1:20,000, 10,701‐1‐AP, Proteintech), p‐AMPK (1:1,000, AF3423, Affinity), AMPK (1:1,000, AF6423, Affinity), PKA (1:1,000, AF7746, Affinity), p‐eNOS (1:1,000, AF3247, Affinity), and eNOS (1:20,000, 27120‐1‐AP, Proteintech). ..

    Mouse Assay:

    Article Title: 4‐Octyl Itaconate Attenuates Age‐Induced Parotid Gland Dysfunction Through the Suppression of Fibrosis and Lipid Deposition by AMPKα/PPARα and the Inhibition of Oxidative Stress via the AMPKα/Nrf2 Signaling Pathway
    Article Snippet: .. Mice in the 13 M + 4‐OI + ML385 group received an i.p. injection of an Nrf2 inhibitor (ML385, 30 mg/kg; HY‐13418A; MedChemExpress, NJ, USA) daily for 4 weeks, whereas the mice in the 13 M group and 2 M group were given vehicle by i.p. injection. ..

    Injection:

    Article Title: 4‐Octyl Itaconate Attenuates Age‐Induced Parotid Gland Dysfunction Through the Suppression of Fibrosis and Lipid Deposition by AMPKα/PPARα and the Inhibition of Oxidative Stress via the AMPKα/Nrf2 Signaling Pathway
    Article Snippet: .. Mice in the 13 M + 4‐OI + ML385 group received an i.p. injection of an Nrf2 inhibitor (ML385, 30 mg/kg; HY‐13418A; MedChemExpress, NJ, USA) daily for 4 weeks, whereas the mice in the 13 M group and 2 M group were given vehicle by i.p. injection. ..

    In Vitro:

    Article Title: Oncogenic MAGEA4 directs neuroendocrine differentiation and survival in prostate cancer cells through the SIRT1/Acetyl-p53/BCL-2 axis.
    Article Snippet: 1 Department of Applied Biology, CSIR-Indian Institute of Chemical Technology (CSIR-IICT), Tarnaka, Uppal Road, Hyderabad 007, Hyderabad, India 2 Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India Abstract Background Neuroendocrine prostate cancer (NEPC) is a highly aggressive and therapy-resistant subtype of prostate cancer (PCa) that emerges following the androgen receptor (AR) targeted therapies.. Identification of potential molecular drivers governing neuroendocrine differentiation (NED) and survival is critical for developing therapeutic strategies.. Cancer-testis antigens of the Melanoma-associated antigen family (MAGE) are the emerging players of oncogenic regulators.



    Similar Products

    97
    MedChemExpress nrf2 pathway
    Nrf2 Pathway, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-p10530/Nrf2/pm42826843-61-3-17
    Average 97 stars, based on 1 article reviews
    nrf2 pathway - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    97
    MedChemExpress nrf2 inhibitor
    Effect of 4‐OI on the metabolomics and transcriptome profile of aged mice parotid glands and enhancement of AMPKα and <t>Nrf2</t> pathway in the parotid gland of aged mice by 4‐OI. OPLS‐DA score plot of metabolites detected in (A) 13 M versus 2 M and (B) 13 M + 4‐OI versus 13 M. (C) The Venn diagram illustrates the differentially expressed metabolites that are particular or common within different comparison groups. (D) KEGG pathway classifications on differential metabolites. The vertical axis represents KEGG compound categories, while the horizontal axis shows the number of compounds annotated to each category. Bar colors indicate the primary classification level of the compounds. Volcano plots plot of differential metabolites detected in (E) 13 M versus 2 M and (F) 13 M + 4‐OI versus 13 M. (G) Histogram displaying the numbers of differential metabolites in 13 M versus 2 M and 13 M + 4‐OI versus 13 M. Heatmap showing the variable importance (VIP) scores of the top 30 differential metabolites in (H) 13 M versus 2 M and (I) 13 M + 4‐OI versus 13 M. Bubble plots illustrate the primary metabolic pathways responsible for the enrichment of differential metabolites in (J) 13 M versus 2 M and (K) 13 M + 4‐OI versus 13 M. Volcano plots plot of DEGs detected in (L) 13 M versus 2 M and (M) 13 M + 4‐OI versus 13 M. (N) Histogram of the numbers of up‐regulated and downregulated DEGs in 13 M versus 2 M and 13 M + 4‐OI versus 13 M. Bubble plots illustrate the primary KEGG pathways responsible for the enrichment of DEGs in (O) 13 M versus 2 M and (P) 13 M + 4‐OI versus 13 M. (Q, R) Representative Western blot and quantitative analysis the protein levels of AMPKα, p‐AMPKα, and PPARα in the parotid gland of different groups of mice ( n = 3). (S, T) Representative Western blot and quantitative analysis the protein levels of Nrf2, Keap1, NQO‐1, and HO‐1 in the parotid gland of different groups of mice ( n = 3). The data are presented as the means ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001. ns, not significant.
    Nrf2 Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-p10530/Nrf2/pmc13624517-61-16-22
    Average 97 stars, based on 1 article reviews
    nrf2 inhibitor - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    97
    MedChemExpress nrf2 signaling pathway
    Effect of 4‐OI on the metabolomics and transcriptome profile of aged mice parotid glands and enhancement of AMPKα and <t>Nrf2</t> pathway in the parotid gland of aged mice by 4‐OI. OPLS‐DA score plot of metabolites detected in (A) 13 M versus 2 M and (B) 13 M + 4‐OI versus 13 M. (C) The Venn diagram illustrates the differentially expressed metabolites that are particular or common within different comparison groups. (D) KEGG pathway classifications on differential metabolites. The vertical axis represents KEGG compound categories, while the horizontal axis shows the number of compounds annotated to each category. Bar colors indicate the primary classification level of the compounds. Volcano plots plot of differential metabolites detected in (E) 13 M versus 2 M and (F) 13 M + 4‐OI versus 13 M. (G) Histogram displaying the numbers of differential metabolites in 13 M versus 2 M and 13 M + 4‐OI versus 13 M. Heatmap showing the variable importance (VIP) scores of the top 30 differential metabolites in (H) 13 M versus 2 M and (I) 13 M + 4‐OI versus 13 M. Bubble plots illustrate the primary metabolic pathways responsible for the enrichment of differential metabolites in (J) 13 M versus 2 M and (K) 13 M + 4‐OI versus 13 M. Volcano plots plot of DEGs detected in (L) 13 M versus 2 M and (M) 13 M + 4‐OI versus 13 M. (N) Histogram of the numbers of up‐regulated and downregulated DEGs in 13 M versus 2 M and 13 M + 4‐OI versus 13 M. Bubble plots illustrate the primary KEGG pathways responsible for the enrichment of DEGs in (O) 13 M versus 2 M and (P) 13 M + 4‐OI versus 13 M. (Q, R) Representative Western blot and quantitative analysis the protein levels of AMPKα, p‐AMPKα, and PPARα in the parotid gland of different groups of mice ( n = 3). (S, T) Representative Western blot and quantitative analysis the protein levels of Nrf2, Keap1, NQO‐1, and HO‐1 in the parotid gland of different groups of mice ( n = 3). The data are presented as the means ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001. ns, not significant.
    Nrf2 Signaling Pathway, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-p10530/Nrf2/pm42487045-64-25-39
    Average 97 stars, based on 1 article reviews
    nrf2 signaling pathway - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    97
    MedChemExpress nrf2 inhibition
    Effect of 4‐OI on the metabolomics and transcriptome profile of aged mice parotid glands and enhancement of AMPKα and <t>Nrf2</t> pathway in the parotid gland of aged mice by 4‐OI. OPLS‐DA score plot of metabolites detected in (A) 13 M versus 2 M and (B) 13 M + 4‐OI versus 13 M. (C) The Venn diagram illustrates the differentially expressed metabolites that are particular or common within different comparison groups. (D) KEGG pathway classifications on differential metabolites. The vertical axis represents KEGG compound categories, while the horizontal axis shows the number of compounds annotated to each category. Bar colors indicate the primary classification level of the compounds. Volcano plots plot of differential metabolites detected in (E) 13 M versus 2 M and (F) 13 M + 4‐OI versus 13 M. (G) Histogram displaying the numbers of differential metabolites in 13 M versus 2 M and 13 M + 4‐OI versus 13 M. Heatmap showing the variable importance (VIP) scores of the top 30 differential metabolites in (H) 13 M versus 2 M and (I) 13 M + 4‐OI versus 13 M. Bubble plots illustrate the primary metabolic pathways responsible for the enrichment of differential metabolites in (J) 13 M versus 2 M and (K) 13 M + 4‐OI versus 13 M. Volcano plots plot of DEGs detected in (L) 13 M versus 2 M and (M) 13 M + 4‐OI versus 13 M. (N) Histogram of the numbers of up‐regulated and downregulated DEGs in 13 M versus 2 M and 13 M + 4‐OI versus 13 M. Bubble plots illustrate the primary KEGG pathways responsible for the enrichment of DEGs in (O) 13 M versus 2 M and (P) 13 M + 4‐OI versus 13 M. (Q, R) Representative Western blot and quantitative analysis the protein levels of AMPKα, p‐AMPKα, and PPARα in the parotid gland of different groups of mice ( n = 3). (S, T) Representative Western blot and quantitative analysis the protein levels of Nrf2, Keap1, NQO‐1, and HO‐1 in the parotid gland of different groups of mice ( n = 3). The data are presented as the means ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001. ns, not significant.
    Nrf2 Inhibition, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-p10530/Nrf2/pm42471410-220-22-31
    Average 97 stars, based on 1 article reviews
    nrf2 inhibition - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    97
    MedChemExpress nrf2
    Effect of 4‐OI on the metabolomics and transcriptome profile of aged mice parotid glands and enhancement of AMPKα and <t>Nrf2</t> pathway in the parotid gland of aged mice by 4‐OI. OPLS‐DA score plot of metabolites detected in (A) 13 M versus 2 M and (B) 13 M + 4‐OI versus 13 M. (C) The Venn diagram illustrates the differentially expressed metabolites that are particular or common within different comparison groups. (D) KEGG pathway classifications on differential metabolites. The vertical axis represents KEGG compound categories, while the horizontal axis shows the number of compounds annotated to each category. Bar colors indicate the primary classification level of the compounds. Volcano plots plot of differential metabolites detected in (E) 13 M versus 2 M and (F) 13 M + 4‐OI versus 13 M. (G) Histogram displaying the numbers of differential metabolites in 13 M versus 2 M and 13 M + 4‐OI versus 13 M. Heatmap showing the variable importance (VIP) scores of the top 30 differential metabolites in (H) 13 M versus 2 M and (I) 13 M + 4‐OI versus 13 M. Bubble plots illustrate the primary metabolic pathways responsible for the enrichment of differential metabolites in (J) 13 M versus 2 M and (K) 13 M + 4‐OI versus 13 M. Volcano plots plot of DEGs detected in (L) 13 M versus 2 M and (M) 13 M + 4‐OI versus 13 M. (N) Histogram of the numbers of up‐regulated and downregulated DEGs in 13 M versus 2 M and 13 M + 4‐OI versus 13 M. Bubble plots illustrate the primary KEGG pathways responsible for the enrichment of DEGs in (O) 13 M versus 2 M and (P) 13 M + 4‐OI versus 13 M. (Q, R) Representative Western blot and quantitative analysis the protein levels of AMPKα, p‐AMPKα, and PPARα in the parotid gland of different groups of mice ( n = 3). (S, T) Representative Western blot and quantitative analysis the protein levels of Nrf2, Keap1, NQO‐1, and HO‐1 in the parotid gland of different groups of mice ( n = 3). The data are presented as the means ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001. ns, not significant.
    Nrf2, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-p10530/Nrf2/pm42090955-118-2-11
    Average 97 stars, based on 1 article reviews
    nrf2 - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    97
    MedChemExpress nrf2 activity
    Effect of 4‐OI on the metabolomics and transcriptome profile of aged mice parotid glands and enhancement of AMPKα and <t>Nrf2</t> pathway in the parotid gland of aged mice by 4‐OI. OPLS‐DA score plot of metabolites detected in (A) 13 M versus 2 M and (B) 13 M + 4‐OI versus 13 M. (C) The Venn diagram illustrates the differentially expressed metabolites that are particular or common within different comparison groups. (D) KEGG pathway classifications on differential metabolites. The vertical axis represents KEGG compound categories, while the horizontal axis shows the number of compounds annotated to each category. Bar colors indicate the primary classification level of the compounds. Volcano plots plot of differential metabolites detected in (E) 13 M versus 2 M and (F) 13 M + 4‐OI versus 13 M. (G) Histogram displaying the numbers of differential metabolites in 13 M versus 2 M and 13 M + 4‐OI versus 13 M. Heatmap showing the variable importance (VIP) scores of the top 30 differential metabolites in (H) 13 M versus 2 M and (I) 13 M + 4‐OI versus 13 M. Bubble plots illustrate the primary metabolic pathways responsible for the enrichment of differential metabolites in (J) 13 M versus 2 M and (K) 13 M + 4‐OI versus 13 M. Volcano plots plot of DEGs detected in (L) 13 M versus 2 M and (M) 13 M + 4‐OI versus 13 M. (N) Histogram of the numbers of up‐regulated and downregulated DEGs in 13 M versus 2 M and 13 M + 4‐OI versus 13 M. Bubble plots illustrate the primary KEGG pathways responsible for the enrichment of DEGs in (O) 13 M versus 2 M and (P) 13 M + 4‐OI versus 13 M. (Q, R) Representative Western blot and quantitative analysis the protein levels of AMPKα, p‐AMPKα, and PPARα in the parotid gland of different groups of mice ( n = 3). (S, T) Representative Western blot and quantitative analysis the protein levels of Nrf2, Keap1, NQO‐1, and HO‐1 in the parotid gland of different groups of mice ( n = 3). The data are presented as the means ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001. ns, not significant.
    Nrf2 Activity, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-p10530/Nrf2/pm42296917-77-12-15
    Average 97 stars, based on 1 article reviews
    nrf2 activity - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    97
    MedChemExpress ar tic le in pr es s nrf2 activation
    Effect of 4‐OI on the metabolomics and transcriptome profile of aged mice parotid glands and enhancement of AMPKα and <t>Nrf2</t> pathway in the parotid gland of aged mice by 4‐OI. OPLS‐DA score plot of metabolites detected in (A) 13 M versus 2 M and (B) 13 M + 4‐OI versus 13 M. (C) The Venn diagram illustrates the differentially expressed metabolites that are particular or common within different comparison groups. (D) KEGG pathway classifications on differential metabolites. The vertical axis represents KEGG compound categories, while the horizontal axis shows the number of compounds annotated to each category. Bar colors indicate the primary classification level of the compounds. Volcano plots plot of differential metabolites detected in (E) 13 M versus 2 M and (F) 13 M + 4‐OI versus 13 M. (G) Histogram displaying the numbers of differential metabolites in 13 M versus 2 M and 13 M + 4‐OI versus 13 M. Heatmap showing the variable importance (VIP) scores of the top 30 differential metabolites in (H) 13 M versus 2 M and (I) 13 M + 4‐OI versus 13 M. Bubble plots illustrate the primary metabolic pathways responsible for the enrichment of differential metabolites in (J) 13 M versus 2 M and (K) 13 M + 4‐OI versus 13 M. Volcano plots plot of DEGs detected in (L) 13 M versus 2 M and (M) 13 M + 4‐OI versus 13 M. (N) Histogram of the numbers of up‐regulated and downregulated DEGs in 13 M versus 2 M and 13 M + 4‐OI versus 13 M. Bubble plots illustrate the primary KEGG pathways responsible for the enrichment of DEGs in (O) 13 M versus 2 M and (P) 13 M + 4‐OI versus 13 M. (Q, R) Representative Western blot and quantitative analysis the protein levels of AMPKα, p‐AMPKα, and PPARα in the parotid gland of different groups of mice ( n = 3). (S, T) Representative Western blot and quantitative analysis the protein levels of Nrf2, Keap1, NQO‐1, and HO‐1 in the parotid gland of different groups of mice ( n = 3). The data are presented as the means ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001. ns, not significant.
    Ar Tic Le In Pr Es S Nrf2 Activation, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-p10530/Nrf2/pm42106749-190-0-35
    Average 97 stars, based on 1 article reviews
    ar tic le in pr es s nrf2 activation - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    Image Search Results


    Effect of 4‐OI on the metabolomics and transcriptome profile of aged mice parotid glands and enhancement of AMPKα and Nrf2 pathway in the parotid gland of aged mice by 4‐OI. OPLS‐DA score plot of metabolites detected in (A) 13 M versus 2 M and (B) 13 M + 4‐OI versus 13 M. (C) The Venn diagram illustrates the differentially expressed metabolites that are particular or common within different comparison groups. (D) KEGG pathway classifications on differential metabolites. The vertical axis represents KEGG compound categories, while the horizontal axis shows the number of compounds annotated to each category. Bar colors indicate the primary classification level of the compounds. Volcano plots plot of differential metabolites detected in (E) 13 M versus 2 M and (F) 13 M + 4‐OI versus 13 M. (G) Histogram displaying the numbers of differential metabolites in 13 M versus 2 M and 13 M + 4‐OI versus 13 M. Heatmap showing the variable importance (VIP) scores of the top 30 differential metabolites in (H) 13 M versus 2 M and (I) 13 M + 4‐OI versus 13 M. Bubble plots illustrate the primary metabolic pathways responsible for the enrichment of differential metabolites in (J) 13 M versus 2 M and (K) 13 M + 4‐OI versus 13 M. Volcano plots plot of DEGs detected in (L) 13 M versus 2 M and (M) 13 M + 4‐OI versus 13 M. (N) Histogram of the numbers of up‐regulated and downregulated DEGs in 13 M versus 2 M and 13 M + 4‐OI versus 13 M. Bubble plots illustrate the primary KEGG pathways responsible for the enrichment of DEGs in (O) 13 M versus 2 M and (P) 13 M + 4‐OI versus 13 M. (Q, R) Representative Western blot and quantitative analysis the protein levels of AMPKα, p‐AMPKα, and PPARα in the parotid gland of different groups of mice ( n = 3). (S, T) Representative Western blot and quantitative analysis the protein levels of Nrf2, Keap1, NQO‐1, and HO‐1 in the parotid gland of different groups of mice ( n = 3). The data are presented as the means ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001. ns, not significant.

    Journal: The FASEB Journal

    Article Title: 4‐Octyl Itaconate Attenuates Age‐Induced Parotid Gland Dysfunction Through the Suppression of Fibrosis and Lipid Deposition by AMPKα/PPARα and the Inhibition of Oxidative Stress via the AMPKα/Nrf2 Signaling Pathway

    doi: 10.1096/fj.202602956RR

    Figure Lengend Snippet: Effect of 4‐OI on the metabolomics and transcriptome profile of aged mice parotid glands and enhancement of AMPKα and Nrf2 pathway in the parotid gland of aged mice by 4‐OI. OPLS‐DA score plot of metabolites detected in (A) 13 M versus 2 M and (B) 13 M + 4‐OI versus 13 M. (C) The Venn diagram illustrates the differentially expressed metabolites that are particular or common within different comparison groups. (D) KEGG pathway classifications on differential metabolites. The vertical axis represents KEGG compound categories, while the horizontal axis shows the number of compounds annotated to each category. Bar colors indicate the primary classification level of the compounds. Volcano plots plot of differential metabolites detected in (E) 13 M versus 2 M and (F) 13 M + 4‐OI versus 13 M. (G) Histogram displaying the numbers of differential metabolites in 13 M versus 2 M and 13 M + 4‐OI versus 13 M. Heatmap showing the variable importance (VIP) scores of the top 30 differential metabolites in (H) 13 M versus 2 M and (I) 13 M + 4‐OI versus 13 M. Bubble plots illustrate the primary metabolic pathways responsible for the enrichment of differential metabolites in (J) 13 M versus 2 M and (K) 13 M + 4‐OI versus 13 M. Volcano plots plot of DEGs detected in (L) 13 M versus 2 M and (M) 13 M + 4‐OI versus 13 M. (N) Histogram of the numbers of up‐regulated and downregulated DEGs in 13 M versus 2 M and 13 M + 4‐OI versus 13 M. Bubble plots illustrate the primary KEGG pathways responsible for the enrichment of DEGs in (O) 13 M versus 2 M and (P) 13 M + 4‐OI versus 13 M. (Q, R) Representative Western blot and quantitative analysis the protein levels of AMPKα, p‐AMPKα, and PPARα in the parotid gland of different groups of mice ( n = 3). (S, T) Representative Western blot and quantitative analysis the protein levels of Nrf2, Keap1, NQO‐1, and HO‐1 in the parotid gland of different groups of mice ( n = 3). The data are presented as the means ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001. ns, not significant.

    Article Snippet: Mice in the 13 M + 4‐OI + ML385 group received an i.p. injection of an Nrf2 inhibitor (ML385, 30 mg/kg; HY‐13418A; MedChemExpress, NJ, USA) daily for 4 weeks, whereas the mice in the 13 M group and 2 M group were given vehicle by i.p. injection.

    Techniques: Comparison, Western Blot, Analysis

    Nrf2 inhibitor reverses 4‐OI's restoration of function and structure impairments in parotid gland in aged mice. (A) Representative images and quantitative analysis of hematoxylin and eosin (H&E) staining in the parotid gland of different groups of mice ( n = 6). Scale bars: 50 μm (top) and 20 μm (bottom). (B) Salivary flow rates in different groups of mice ( n = 6). (C, D) Representative Western blot and quantitative analysis the protein levels of Nrf2, Keap1, NQO‐1, and HO‐1 in the parotid gland of different groups of mice ( n = 3). (E) Representative images of immunofluorescent staining for Nrf2 (red) and DAPI (blue) and quantitative analysis of relative fluorescence intensity of Nrf2 in the parotid gland of different groups of mice ( n = 6). Scale bars: 50 μm. The data are presented as the means ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001. ns, not significant.

    Journal: The FASEB Journal

    Article Title: 4‐Octyl Itaconate Attenuates Age‐Induced Parotid Gland Dysfunction Through the Suppression of Fibrosis and Lipid Deposition by AMPKα/PPARα and the Inhibition of Oxidative Stress via the AMPKα/Nrf2 Signaling Pathway

    doi: 10.1096/fj.202602956RR

    Figure Lengend Snippet: Nrf2 inhibitor reverses 4‐OI's restoration of function and structure impairments in parotid gland in aged mice. (A) Representative images and quantitative analysis of hematoxylin and eosin (H&E) staining in the parotid gland of different groups of mice ( n = 6). Scale bars: 50 μm (top) and 20 μm (bottom). (B) Salivary flow rates in different groups of mice ( n = 6). (C, D) Representative Western blot and quantitative analysis the protein levels of Nrf2, Keap1, NQO‐1, and HO‐1 in the parotid gland of different groups of mice ( n = 3). (E) Representative images of immunofluorescent staining for Nrf2 (red) and DAPI (blue) and quantitative analysis of relative fluorescence intensity of Nrf2 in the parotid gland of different groups of mice ( n = 6). Scale bars: 50 μm. The data are presented as the means ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001. ns, not significant.

    Article Snippet: Mice in the 13 M + 4‐OI + ML385 group received an i.p. injection of an Nrf2 inhibitor (ML385, 30 mg/kg; HY‐13418A; MedChemExpress, NJ, USA) daily for 4 weeks, whereas the mice in the 13 M group and 2 M group were given vehicle by i.p. injection.

    Techniques: Analysis, Staining, Western Blot, Fluorescence

    AMPKα inhibitor reverses 4‐OI's alleviation of apoptosis, inflammation, and mitochondrial dysfunction in parotid gland in aged mice. (A) Representative ROS‐induced fluorescence staining images labeled with DHE dye (red) and DAPI (blue), accompanied by (C) quantitative analysis of relative DHE fluorescence intensity in the parotid glands of mice from different groups ( n = 6). (B) Representative images and (D) quantitative analysis of JC‐1 staining in the parotid glands of mice from different groups ( n = 6). Scale bar: 50 μm (top) and 20 μm (bottom). (E) Representative transmission electron microscopy image of mitochondria in the parotid glands of 2 M, 13 M, 13 M + 4‐OI, and 13 M + 4‐OI + CC groups. Scale bars: 1 μm (top) and 500 nm (bottom). (F, G) Representative Western blot and quantitative analysis the protein levels of PGC‐1α, TFAM, and cytochrome c in the parotid gland of different groups of mice ( n = 3). (H, I) Representative Western blot and quantitative analysis the protein levels of AMPKα, p‐AMPKα, SIRT1, GSK3β, p‐GSK3β, Nrf2, and Keap1 in the parotid gland of different groups of mice ( n = 3). (J) Representative images of immunofluorescent staining for Nrf2 (red) and DAPI (blue) and HO‐1 (red) and DAPI (blue) in the parotid gland of different groups of mice. Scale bars: 50 μm. (K, L) Representative Western blot and quantitative analysis the protein levels of TLR4, NF‐κB p65, p‐NF‐κB p65, IκB‐α, and p‐IκB‐α in the parotid gland of different groups of mice ( n = 3). (M, N) Representative Western blot and quantitative analysis the protein levels of NLRP3, TNF‐α, P16 INK4A , P21, and P53 in the parotid gland of different groups of mice ( n = 3). (O) Representative images and quantitative analysis of senescence‐associated β‐galactosidase (SA‐β‐gal) staining in the parotid gland of different groups of mice ( n = 6). Scale bars: 50 μm. (P) Representative images of immunofluorescent staining for 8‐OHdG (red) and DAPI (blue) in the parotid gland of different groups of mice. Scale bars: 50 μm. (Q) Representative images of immunofluorescent staining for TUNEL (red) and DAPI (blue) and quantitative analysis of TUNEL positive cells in the parotid gland of different groups of mice ( n = 6). Scale bars: 50 μm. The data are presented as the means ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001. DHE, dihydroethidium; ns, not significant; ROS, reactive oxygen species.

    Journal: The FASEB Journal

    Article Title: 4‐Octyl Itaconate Attenuates Age‐Induced Parotid Gland Dysfunction Through the Suppression of Fibrosis and Lipid Deposition by AMPKα/PPARα and the Inhibition of Oxidative Stress via the AMPKα/Nrf2 Signaling Pathway

    doi: 10.1096/fj.202602956RR

    Figure Lengend Snippet: AMPKα inhibitor reverses 4‐OI's alleviation of apoptosis, inflammation, and mitochondrial dysfunction in parotid gland in aged mice. (A) Representative ROS‐induced fluorescence staining images labeled with DHE dye (red) and DAPI (blue), accompanied by (C) quantitative analysis of relative DHE fluorescence intensity in the parotid glands of mice from different groups ( n = 6). (B) Representative images and (D) quantitative analysis of JC‐1 staining in the parotid glands of mice from different groups ( n = 6). Scale bar: 50 μm (top) and 20 μm (bottom). (E) Representative transmission electron microscopy image of mitochondria in the parotid glands of 2 M, 13 M, 13 M + 4‐OI, and 13 M + 4‐OI + CC groups. Scale bars: 1 μm (top) and 500 nm (bottom). (F, G) Representative Western blot and quantitative analysis the protein levels of PGC‐1α, TFAM, and cytochrome c in the parotid gland of different groups of mice ( n = 3). (H, I) Representative Western blot and quantitative analysis the protein levels of AMPKα, p‐AMPKα, SIRT1, GSK3β, p‐GSK3β, Nrf2, and Keap1 in the parotid gland of different groups of mice ( n = 3). (J) Representative images of immunofluorescent staining for Nrf2 (red) and DAPI (blue) and HO‐1 (red) and DAPI (blue) in the parotid gland of different groups of mice. Scale bars: 50 μm. (K, L) Representative Western blot and quantitative analysis the protein levels of TLR4, NF‐κB p65, p‐NF‐κB p65, IκB‐α, and p‐IκB‐α in the parotid gland of different groups of mice ( n = 3). (M, N) Representative Western blot and quantitative analysis the protein levels of NLRP3, TNF‐α, P16 INK4A , P21, and P53 in the parotid gland of different groups of mice ( n = 3). (O) Representative images and quantitative analysis of senescence‐associated β‐galactosidase (SA‐β‐gal) staining in the parotid gland of different groups of mice ( n = 6). Scale bars: 50 μm. (P) Representative images of immunofluorescent staining for 8‐OHdG (red) and DAPI (blue) in the parotid gland of different groups of mice. Scale bars: 50 μm. (Q) Representative images of immunofluorescent staining for TUNEL (red) and DAPI (blue) and quantitative analysis of TUNEL positive cells in the parotid gland of different groups of mice ( n = 6). Scale bars: 50 μm. The data are presented as the means ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001. DHE, dihydroethidium; ns, not significant; ROS, reactive oxygen species.

    Article Snippet: Mice in the 13 M + 4‐OI + ML385 group received an i.p. injection of an Nrf2 inhibitor (ML385, 30 mg/kg; HY‐13418A; MedChemExpress, NJ, USA) daily for 4 weeks, whereas the mice in the 13 M group and 2 M group were given vehicle by i.p. injection.

    Techniques: Fluorescence, Staining, Labeling, Analysis, Transmission Assay, Electron Microscopy, Western Blot, TUNEL Assay